2017-03-28

[#DIV28SUPER] Fwd: For Div 28 list serv- Psychological Services- Call for Papers on Clinical Apps

 

   

    

    

    

 

 

Open Call for Manuscripts

Special Issue on “Clinical Apps and Public Service Settings”

Psychological Services

Deadline: June 30, 2017

 

The editorial staff of Division 18’s APA journal Psychological Services would like to invite you to submit articles for a special issue on Clinical Apps and Public Service Settings that will be edited by Femina P. Varghese, PhD, Gary R. VandenBos, PhD., and Guest Editor Julia Hoffman, Psy.D.

 

The growing prevalence of mobile devices has also increased the development of mobile applications for a wide range of uses.  Applied psychology is not exempt from this trend, and mobile applications, termed “clinical apps,” are continuing to be developed to supplement treatment and assessment.  However, the scholarly literature on such clinical apps is still somewhat lacking.  Reviews and comparative analyses of clinical apps would expand providers’ awareness of such apps and inform providers on how to most effectively utilize them in the comprehensive treatment of clients.  Given the need for more literature on the development, use, and effectiveness of clinical apps for public service settings and populations, this special issue is focused on publishing papers that cover clinical apps broadly, including reviews, empirical studies, innovative developments, and policy papers.  Considering the nature of the journal, papers should be focused on the use of clinical apps in organized care settings such as community mental health settings, community health centers, schools, child guidance clinics, rehab units, correctional settings, police departments, jails, prisons, courts, probation departments, Indian Health Service, special services departments, university clinics, training hospitals, local/state hospitals, and local government agencies.

This special section will be devoted to all aspects of clinical apps and public service settings, including, but not limited to:

·   Clinical apps for the diagnosis and treatment of specific behavioral problems, emotional disturbance, mental illness, and physical health issues

·   Clinical outcome data on the use of specific apps or types of clinical apps

·   Reviews on apps developed for specific issues and populations (e.g., military, corrections, youth, integrated care settings, and school systems)

·   Comparative reviews of ease of use and utility of data from different clinical apps attempting to assess, measure or monitor the same problem behavior

·   Evidenced based and empirically supported treatments with the use of clinical apps

·   Integrating clinical apps with psychotherapy and other treatments

·   Patient and provider experiences in the use of apps

·   Ethical considerations in the use of clinical apps

·   Measurement issues with clinical apps

·   Quality enhancement issues with clinical apps

In sum, we welcome manuscripts related to a variety of topics related to Clinical Apps in Public Service Settings, including empirical, conceptual, and theoretical papers focused on service provision.

The deadline for receipt of papers for this special section is June 30, 2017. Please follow the Instructions to Authors information located on the Psychological Services website at: http://www.apa.org/pubs/journals/ser .  Manuscripts must be submitted electronically through the Manuscript Submission Web Portal as described on the journal's website, here: http://www.editorialmanager.com/svs/

 

Please specify in your cover letter that the submission is intended for the special section on Clinical Apps and Public Service Settings and address your submission cover letter to Dr. Femina P. Varghese, Dr. Gary R. VandenBos, and Dr. Julia Hoffman. 

 

All papers submitted will be initially screened by the editorial board and then sent out for blind peer review. If evaluated as appropriate for the journal, papers will then be sent out for blind peer review.

 

For further questions related to this special section, please contact Dr. Vandenbos at drgaryvandenbos@gmail.com, Dr. Varghese at fvarghese@uca.edu, and Dr. Hoffman at  Julia.Hoffman@va.gov.

 

 

 

 

 



Sent from my iPhone

Begin forwarded message:

From: "Meadows, Mare" <MMeadows@apa.org>
Date: March 28, 2017 at 12:32:53 PM EDT
To: "Ronald_wood@urmc.rochester.edu" <Ronald_wood@urmc.rochester.edu>
Subject: For Div 28 list serv- Psychological Services- Call for Papers on Clinical Apps

Hi Ronald,

 

If of any interest to the Division 28 list servs, I am attaching (and pasting below) a call for papers for a special issue on clinical apps in Psychological Services. Please feel free to distribute if you wish.

 

Thanks,

Mare

 

 

Mare Meadows | Managing Director, Journals

Publications & Databases | 202-336-6073 | mmeadows@apa.org  

American Psychological Association

www.apa.org

 

Advancing psychology to benefit society and improve people’s lives

2017-03-22

[#DIV28SUPER] 65th NE Symposium on Motivation

The 65th Nebraska Symposium on Motivation will be April 20-21.

 http://psychology.unl.edu/symposium


The theme is "Change and Maintaining Change" with the following participants...


Dolores Albarracin, Ph.D. (University of Illinois)
Chloe Bird, Ph.D. (RAND)
Stephen Higgins, Ph.D. (University of Vermont)
George Koob, Ph.D. (NIAAA)
Greg Madden, Ph.D. (Utah State University)
Connie Roser-Renouf, Ph.D. (George Mason University)

We invite you to attend (registration is free) and to participate in the poster session and reception on that Thursday (4/20). The deadline for posters is April 5th but we will be making decisions as they come in so poster presenters can make travel arrangements.  Only a 50 to 100 word abstract is needed and any topic relevant to motivation and/or change is fine.  Details for poster submission are on the web page  psychology.unl.edu/symposium


Please spread the word to colleagues and distribute to listserves and other outlets as you see fit.

See you in April,
Rick

2017-03-20

[#DIV28SUPER] Job Posting

Postdoctoral Fellowship in Behavioral Toxicology/Pharmacology, Division of Neurotoxicology, National Center for Toxicological Research, US FDA

 

The U.S. Department of Health and Human Services, Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR), Division of Neurotoxicology in the Office of Research is seeking to hire a highly qualified scientist to assist with ongoing research projects into the neurotoxic effects of commonly used pediatric anesthetic agents. The successful candidate will participate in multi-disciplinary research efforts in a nationally recognized research program in support of FDA's mission.  Primary responsibilities for this position will be to oversee sophisticated behavioral assessments of young nonhuman primates (rhesus monkeys) and rodents after neonatal or adult exposures to general anesthetic drugs commonly employed in the pediatric and general clinical setting.  A major focus of the research will involve the use of operant behavioral techniques to monitor specific aspects of cognitive function.  The opportunity to participate in additional translational research in children will depend upon the interest of the Fellow and demonstrated productivity. 

 

The NCTR, located approximately 30 miles southeast of Little Rock conducts FDA mission-related research that is of critical importance to the Agency in developing a scientifically sound basis for regulatory decisions.  Over 110 Ph.D. scientists and 400 support scientists, on-site-contractors and administrative staff make up a dynamic group of professionals in the NCTR organization. Undergraduate and graduate students, post-doctoral fellows and visiting scientists also pursue education and research opportunities in a multi-disciplinary team atmosphere.  For more information on NCTR research and training activities, visit http://www.fda.gov/NCTR.

 

This position requires a Ph.D., M.D., or equivalent, in the fields of Pharmacology, Toxicology, Developmental Psychobiology, Biological Psychology, Experimental Psychology or Comparative Psychology with an emphasis on animal learning and behavior.  A history of productive research is highly desirable.  Preference will be given to individuals with a demonstrated record of relevant accomplishments.  Evidence of effective organizational and decision-making capabilities and interpersonal and communication skills are required.  The salary will be approximately $58,000 annually.

 

The selected candidate for this position will be on a non-federal government appointment.  Interested individuals should send a letter of application with a curriculum vitae, statement of research experience and interests, a sample of peer reviewed publication(s), and names of three references with complete contact information to the attention of Merle G. Paule, Ph.D., Director, Division of Neurotoxicology, National Center for Toxicological Research/FDA, 3900 NCTR Road, Jefferson, Arkansas 72079; phone 870-543-7203; fax 870-543-7745; Email:  Merle.Paule@fda.hhs.gov .  Applications will be accepted until the position is filled.  FDA is an Equal Opportunity Employer.  FDA/NCTR is a smoke free environment.

 


2017-03-18

[#DIV28SUPER] Fwd: APA Endorses March for Science

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

2017-03-17

[#DIV28SUPER] UVM NIH POSTDOCTORAL RESEARCH FELLOWSHIP POSITION

NIH Postdoctoral Research Fellowship Opportunity

 

The University of Vermont’s Center on Behavior and Health (VCBH) announces NIH postdoctoral research fellowship opportunities in our internationally recognized center of excellence for the study of substance abuse. 

Eligibility: Applicants must have completed their training in psychology, behavior analysis, or a related discipline and be U.S. citizens or permanent residents. Trainees are selected on the basis of scholastic record and commitment to a career in substance abuse research. Individuals must be highly motivated, possess initiative and a desire to learn and expand their interests and expertise.

 

 Appointment:  2-3 yrs.

 

 Benefits: Stipend, medical insurance coverage, and travel funds supported by NIH Institutional Training Awards.

 

To apply: Send application form (downloaded from VCBH website), a cover letter, curriculum vitae, statement of research interests, and 3 letters of reference to:  Dr. Stephen Higgins c/o Ms. Marissa Wells (mwells2@uvm.edu).

 

About us: The VCBH was established in 2013, sponsored in part by a Centers of Biomedical Research Excellence (COBRE) Award from the National Institute on General Medical Sciences and a Centers of Tobacco Regulatory Science (TCORS) Award from the National Institute on Drug Abuse. The VCBH resides within the College of Medicine at the University of Vermont, with the director and administrative offices being located within the Department of Psychiatry, and participating investigators, collaborators, and advisors across 15 academic departments in the College of Medicine and 7 colleges within the University of Vermont and 5 other universities. The VCBH is further strengthened by interdisciplinary collaborations with key community healthcare leaders and distinguished scientific advisory panels. The focus of the VCBH is on investigating relationships between personal behaviors and risk for chronic disease and premature death, with a specific focus on understanding mechanisms underpinning risk, and developing effective interventions and policies to promote healthy behavior.

 

 For more information:  Contact Ms. Marissa Wells at mwells2@uvm.edu or see our website.

 

 

 Burlington, Vermont is located in the beautiful Lake Champlain region, surrounded by the Green and Adirondack Mountains. It is a great place for families, boasting excellent schools and year-round recreational opportunities. It is home to the University of Vermont and many other colleges that provide an academically stimulating and culturally rich environment. Montreal and Boston are within easy driving distances.


--

Stephen T. Higgins, Ph.D.
Director, Vermont Center on Behavior and Health
Virginia H. Donaldson Professor of Translational Science
Departments of Psychiatry and Psychology
Vice Chair, Department of Psychiatry
University of Vermont
1 South Prospect Street
Burlington, VT  05401-1419

VCBH Administrator: Marissa Wells
mwells2@uvm.edu
802-656-0079

2017-03-16

[#DIV28SUPER] 13th Annual RSA Mechanisms of Behavior Change Satellite Session Call for Awards

Dear friends and colleagues,

 

Registration for the 13th Annual Mechanisms of Behavior Change satellite session is now open.  At our website you will find a registration form for the upcoming session.   Thanks to generous support from the NIAAA (U13 AA024013) we will also be offering several travel awards to attend the meeting. Information about applications for the travel awards is attached to this message and available onlineTravel award applications are due March 21, 2017.

 

The session will take place from 9:00am-4:00pm on Saturday, June 24th, the day of the opening reception for RSA.  Program details are still being finalized. Please check back for updates.  As always, registration is free.  Please register by May 1st to reserve your space at the meeting!  We would also appreciate if you forward this email to colleagues and trainees who might be interested in attending. 

 

To register and find more information about the day please go to the link:
http://casaa.unm.edu/mechanismsofchange/

 

Thank you for your time and interest,

Katie Witkiewitz and Mitch Karno

Program Committee, Co-Chairs

 

 

Katie Witkiewitz, PhD

President, Society of Addiction Psychology (APA Division 50)

Associate Professor

Department of Psychology

Center on Alcoholism, Substance Abuse, and Addictions

MSC03-2220

University of New Mexico

Albuquerque NM 87131

Office phone: 505-277-5953

Vmail: 505-295-2334

Fax: 505-277-1394

http://casaa.unm.edu/kwitkiewitz.html

 

2017-03-12

[#DIV28SUPER] Interested in updates regarding the ACA?



 
If you are interested in learning more about what is happening to the Affordable Care Act, check out the APAPO capwiz link at practicecentral for updates.


As always, I am happy to provide advocacy information to any APA or Division member studying or working in the area of addiction and mental health.  Learning about the capwiz link and potentially signing up there for updates will also help you to better connect to very specific, professionally-focused information in a more timely manner.  


Thanks-
Nancy

Nancy A. Piotrowski, Ph.D.
Core Faculty & Lead, Addiction Psychology
Harold Abel School of Social & Behavioral Sciences
Department of Psychology, College of Professional Studies,
Capella University
 
Committee of State Leaders, American Psychological Association
Federal Advocacy Coordinator, Div50, American Psychological Association

Membership Chair, Div34, American Psychological Association
Local Advocacy Network Chair, Napa Solano Psychological Association 
Chair, Long Term Finance Committee, San Francisco Psychological Association
 
MAIL:  P.O. Box 5525, Vallejo, California 94591-0552
With Offices in the San Francisco Bay Area
Text or Message:  707.561.2358
Call or Message:  415.386.4923
FAX by request
 
Email:              napiotrowski@yahoo.com
ALT Email:       PiotrowskiConsultation@gmail.com
Skype:             napiotrowski
 

IMPORTANT NOTICE: This transmission and any attachments are intended only for the individual or entity to which it is addressed and may contain information that is privileged, confidential or exempt from disclosure under applicable federal or state laws.  If the reader of this transmission is not the intended recipient, you are hereby notified that any use, dissemination, distribution or copying of this communication, without explicit written communication to handle otherwise, is strictly prohibited.  If you have received this transmission in error, please notify me immediately by email.



From: Ronald Wood <ronaldwood@GMAIL.COM>
To: DIV28SUPER@LISTS.APA.ORG
Sent: Saturday, March 11, 2017 2:57 AM
Subject: [#DIV28SUPER] Rick Barnett: eloquent advocate for RxP in Vermont



Sent from my iPhone

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members  #div28  subscribers corner: http://lists.apa.org


2017-03-10

[#DIV28SUPER] Affordable Care Act revision leaves science largely untouched

APA Science Government Relations News Update:

Affordable Care Act revision leaves science largely untouched

Psychological research funded through the Patient Centered Outcomes Research Institute is not being considered among proposed changes…so far.

 

The Republican leadership of the House of Representatives has just rolled out its plan to revise the Patient Protection and Affordable Care Act (ACA) and while in a letter to the Chairs of the two Committees who have so far passed the bill, APA has expressed broad concerns about the new bill, the provision of ACA that funds research, the Patient Centered Outcomes Research Institute (PCORI), appears to be under the radar for now.

 

Read the full article

 

Geoffrey K. Mumford, Ph.D| Associate Executive Director for Government Relations

Science Directorate | 202.336.6067 | gmumford@apa.org 

American Psychological Association

www.apa.org

 

Advancing psychology to benefit society and improve people’s lives

 

                

 

 

[#DIV28SUPER] Position at Dartmouth


Position Title  

Faculty Position in Intervention Research Methods in Behavioral Health

 Position Description  

 The Department of Biomedical Data Science at the Geisel School of Medicine at Dartmouth (Geisel) seeks an outstanding individual to join our faculty.  The successful candidate is one pursuing a vigorous, research program focused on the use of novel methodologies to develop and/or evaluate adaptive interventions, including just-in-time adaptive interventions and mobile interventions for health behavior change.  Research focused on patient/consumer engagement, clinical effectiveness, and/or implementation of mobile health behavior change interventions will be considered.   Research designed to understand mechanisms of behavior change with digital health interventions is also of interest, as are interventions focusing on addictive behaviors.

The successful individual will be provided a tenure-track faculty appointment in the Department of Biomedical Data Science at the Geisel School of Medicine at Dartmouth College commensurate with experience.  Candidates at the level of associate professor will be preferred, but more junior appointments may also be considered.

Applicants must have earned a PhD and/or MD (or equivalent), have formal advanced training in behavioral science, research methods, or a related field, and should have a successful track record of peer-reviewed publications, and a history of extramural funding.  Expectations for teaching and mentoring are a critical part of this role, and individuals will be provided with such opportunities through membership in relevant PhD graduate programs (e.g., Program in Quantitative Biomedical Sciences; Program in Experimental & Molecular Medicine). Training grants in relevant areas (e.g., Science of Co-occurring Disorders and the Burroughs Wellcome training fund for Unifying Population and Laboratory-based Sciences) are available to support trainees in areas relevant to successful candidates.

Candidates may also have potential affiliations with the Center for Technology and Behavioral Health (CTBH), an interdisciplinary research group whose mission is to inform the optimal development, systematic evaluation, and sustainable implementation of digital therapeutics for behavioral health and health care delivery transformation, the Norris Cotton Cancer Center (NCCC; one of 47 comprehensive cancer centers), or the C. Everett Koop Institute at Dartmouth whose mission is to form partnerships to design and implement model programs and methods to enhance our understanding of mental and physical health and the prolongation of a high quality of life.  The successful candidate will also have opportunities for innovative research method development and application across the translational research pipeline through core departments (e.g., Biomedical Data Science, Epidemiology, Computer Science), The Dartmouth Institute for Health Policy and Clinical Care (TDI), The Population Health Collaboratory, supercomputing networks (e.g., Discovery) and Dartmouth's Clinical and Translational Science Institute (CTSA; called Synergy at Dartmouth).

The Geisel School of Medicine at Dartmouth College is located in the picturesque Upper Connecticut River Valley on the NH and VT border; a vibrant, academic and professional community offering excellent schools, lively arts, and an unmatched quality of life in a beautiful setting. Amenities associated with urban areas of Boston MA, Burlington VT, and Montreal QC are within close proximity.

Application Instructions  

Applicants should submit a cover letter (addressed to Chair of the Search Committee, Dr. Tracy Onega, Ph.D.), a curriculum vitae, and a 2-3 page description of their research interests and future research plans and a list of three phone references. Review of applications will begin on March 15 continue until the position is filled.

Position URL

apply.interfolio.com/40705

 

 

2017-03-04

[#DIV28SUPER] PDF of Agenda

My apologies, it has come to my attention that the inline image of the agenda for the Trans-Disease Decision Processes and Therapeutics Conference did not show up in the message I recently sent. I have attached a pdf of the agenda for your reference.
-Bill Stoops.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2017-03-03

[#DIV28SUPER] Call for Posters

Trans-Disease Decision Processes and Therapeutics Conference – May 25, 2017

Call for Poster Submissions

 

Trainees and early career investigators are invited to submit posters to the inaugural meeting of the Society of Trans-Disease Decision Processes and Therapeutics (TDDPT), to be held May 25, 2017 at the Sheraton Boston Hotel.  This meeting precedes the 29th Annual Convention of the Association for Psychological Science in Boston, MA.  Applications for abstract submission are due by May 1, 2017.

 

This is an opportunity to present novel research on the conference themes such as, though not limited to:

 

1.      self-regulatory dysfunction processes evident across multiple disorders and/or limited to one or a small number of disorders;

2.      whether self-regulatory dysfunction is evident prior to onset or emerges after disorder onset; 

3.      identification of those self-regulatory dysfunction processes that have a genetic basis and may function as endophenotypes;

4.      exploration of interventions to ameliorate self-regulatory dysfunction to decrease disease burden;

5.      determination of whether the interventions shown to improve the self-regulatory dysfunction in one disorder effectively operate in all the disorders in which this dysfunction is present. Such themes could be addressed at multiple levels of analysis (e.g., behavioral, neural, and genetic).

 

To help defer travel costs to the TDDPT meeting, up to five travel awards of $200 each will be given to investigators who submit abstracts.  In addition, two poster submissions will be awarded $500 each for excellence in research and presentation at the conference.

 

Ten symposium presentations will precede the poster session on May 25, as listed in the program below.  For more information on free registration and abstract submission, please visit our website at https://www.transdiseasedecisions.com

 

Questions may be directed to Warren K. Bickel, Ph.D. at wkbickel@vtc.vt.edu or Patsy Marshall at 540-526-2015 or patsym@vtc.vt.edu.

 

2017 SOBC Agenda


               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2017-03-02

[#DIV28SUPER] Applications due April 15, 2017 for Cellular Biology of Addiction CSHL August 8-14, 2017

Application for the CSHL Course on Cellular Biology of Addiction are due April 15, 2017.

Scholarship funds are available for partial support of tuition, room and board on a merit basis. Substantial scholarship funds are available for partial support of tuition, room and board on a merit basis. Please apply in writing when you apply stating the need for financial aid. 

 

August 8 - 14, 2017

Applications due: April 15

Instructors

 

David Belin, University of Cambridge, United Kingdom
Antonello Bonci, National Institute on Drug Abuse
Christopher Evans, University of California, Los Angeles
Brigitte Kieffer, Douglas Research Centre at McGill University, Canada

 

Drug addiction is the most costly neuropsychiatric disorder faced by our nation. Acute and repeated exposure to drugs produces neuroadaptation and long-term memory of the experience, but the cellular and molecular processes involved are only partially understood. The primary objective of this proposed workshop is to provide an intense dialogue of the fundamentals, state-of-the-art advances and major gaps in the cell and molecular biology of drug addiction. Targeted to new or experienced investigators, the workshop will combine formal presentations and informal discussions to convey the merits and excitement of cellular and molecular approaches to drug addiction research. With the advent of genomics and proteomics, an extraordinary opportunity now exists to develop comprehensive models of neuroadaptative processes fundamental to addiction, withdrawal, craving, relapse to drug use and general brain function. A range of disciplines and topics will be represented, including noninvasive brain imaging to identify drug targets and adaptive processes; neuroadaptative processes at the molecular and cellular level, neural networks and their modulation, the relevance of genotype to susceptibility and drug response; tolerance and adaptation at the cellular level and approaches to exploiting the daunting volume generated by neuroinformatics. This workshop will provide an integrated view of current and novel research on neuroadaptive responses to addiction, foster discussion on collaboration and integration, provide critical information needed to construct a model of addiction as a disease and novel molecular targets for biological treatments. Beyond the plane of scientific endeavor, the information is vital for formulating public policy and for enlightening the public on the neurobiological consequences of drug use and addiction. This workshop is designed to generate interest in this level of analysis, open conduits for collaborations and present novel routes to investigating the neurobiology of addictive drugs. 

 

 

 

 

 

 

Cold Spring Harbor Laboratory Meetings & Courses | 1 Bungtown Road Cold Spring Harbor, 11724

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309